Belogo (Belogo)
Sodium Nitroprusside Injection
Product Images NDC 71839-120
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 71839-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Nitroprussidecartonlabel (Nitroprussidecartonlabel)
Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) label for intravenous infusion only by BE Pharmaceuticals Inc. The label includes dilution instructions, a caution to monitor blood pressure during administration, storage conditions, and is marked for single-dose fliptop vial use. Barcode and NDC 71839-120-01 are visible.*
Nitroprussidesleevecarton (Nitroprussidesleevecarton)
Label for Sodium Nitroprusside Injection, emphasizing the inclusion of a Light Protective Sleeve to shield the infusion solution from light exposure. The label repeats this information multiple times and includes a BE Pharmaceuticals Inc. logo. The numeric code 20002368 is also visible on the label.*
Nitroprussidesleevelabel (Nitroprussidesleevelabel)
Label text panel for Sodium Nitroprusside infusion. It includes fields to fill in mg amount and mL volume with 5% Dextrose Injection diluent and spaces to record dilution and expiration dates and times. Instructions emphasize discarding solution 24 hours after dilution, not adding other medications, and protecting the infusion from light using a sleeve or opaque material. Distributed by BE Pharmaceuticals Inc., Cary, NC, made in India.*
Nitroprussideviallabel (Nitroprussideviallabel)
Label for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) by BE Pharmaceuticals Inc. It is for intravenous infusion only, in a 2 mL single-dose flipt top vial. The label includes storage instructions to protect from light and advises monitoring blood pressure before and during administration. The product is made in India and distributed by BE Pharmaceuticals Inc., Cary, NC.*
Sodmet (Sodmet)
An illustration diagram depicting the metabolism pathway of Sodium Nitroprusside. It shows the conversion between active and inactive cytochromes, interaction with hemoglobin to form methemoglobin and various intermediates such as cyanide and thiocyanate, and the renal excretion of metabolites including thiosulfate and thiocyanate.*
Structure (Structure)
Chemical structure diagram of Sodium Nitroprusside showing an iron (Fe) center coordinated with cyanide (CN) and nitrosyl (ON) ligands, along with sodium ions (Na+) and water molecules (H2O) as represented.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
